Following the establishment of the renal cancer circulating tumor cell line 786-O-CTC as depicted in Fig. 2A, we examined the expression of CCL5 both at the transcriptional and protein levels (Fig. 2B), revealing an elevated expression of CCL5 in 786-O-CTC. The gene discussed is CCL5; the disease is neoplasm.